On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
randomized withdrawal design
.
Show all posts
Showing posts with label
randomized withdrawal design
.
Show all posts
Friday, December 15, 2023
Randomized start design (RSD), delayed start design, randomized withdrawal design to assess disease modification effect
›
In the latest Global CardioVascular Clinical Trialists (CVCT) Workshop ", one of the topics was "How to assess the disease modific...
Wednesday, May 17, 2023
Another successful trial with randomized withdrawal design
›
Biotech company PTC Therapeutics announced today that their phase III study of Sepiapterin in PKU patients achieved the primary efficacy en...
Tuesday, November 29, 2022
Randomized withdrawal design in action - Accord trial in Alzheimer's agitation
›
The biotech company, Axsome Therapeutics, announced the positive results from one of their pivotal phase 3 studies (Accord study). Axsome...
2 comments:
›
Home
View web version
